Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Alliance for Detection of Colon Cancer

By Labmedica staff writers
Posted on 01 Aug 2002
A long-term strategic partnership has been announced to commercialize a DNA test for the early detection of colorectal cancer in the average-risk population. More...


Under their agreement, Laboratory Corporation of America Holdings (Burlington, NC, USA) will pay the developer of the test, Exact Sciences Corp. (Maynard, MA, USA), royalty fees and up to US$75 million in various payments for a five-year exclusive license, followed by a nonexclusive license for the life of the patents. Exact Sciences says there is no other DNA test currently available for the early detection of colorectal cancer in an average-risk population.

Called PreGen-Plus, the test works by isolating human DNA, shed in the colon every day and carried out of the body in stool, and by analyzing that DNA for mutations associated with colorectal cancer. PreGen-Plus is noninvasive and requires no dietary modification or bowel preparation. The process involves collecting a single stool sample and shipping the sample in a supplied container to a laboratory for analysis.

"We believe PreGen-Plus could be the most important molecular test identified to date for the millions of Americans who are candidates for colorectal cancer screening annually,” said Thomas P. MacMahon, chairman and CEO of LabCorp.




Related Links:
LabCorp
Exact Sciences

Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: New findings show unique pathogen‑directed antibody patterns are already present years ahead of a formal diagnosis of inflammatory bowel disease (Image Credit: iStock)

Antibody Profiling Identifies Preclinical Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease often develops after a prolonged symptom-free period, complicating timely recognition and clinical intervention. Limited understanding of immune activity during this silent phase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.